GlaxoSmithKline Vaccines

Principal investigator: 
Dr. Roberto Adamo

GSK is one of the world’s leading vaccine companies, involved in vaccine research, development and production. GlaxoSmithKline has 14 vaccines in development and our broad portfolio of 41 vaccines is aimed at preventing illnesses such as hepatitis A, hepatitis B, diphtheria, tetanus, whooping cough, measles, mumps, rubella, polio, typhoid, influenza and bacterial meningitis. Globally, GSK has more than 16,000 people working to deliver more than 2 (2.3) million vaccines every day, to people in 166 countries.

GSK’s Research Centre in Siena is located in a scientific campus that also includes other scientific parks such as TLS (Toscana life science) and GVGH (GSK Vaccines Institute for Global Health), thus creating a dynamic environment where basic science, sophisticated technologies and exploitation can optimally complement one another.